Transporter

A transporter is a membrane protein that shuttles specific molecules from one side of a cell membrane to the other. Unlike a passive channel — which simply opens and lets molecules diffuse through — a transporter binds its cargo and undergoes a structural change to carry it across, a process that typically exploits an existing electrochemical gradient or draws on cellular energy.

In psychopharmacology, the transporters discussed most often are the monoamine reuptake transporters: proteins on the outer surface of neurons that pull neurotransmitters back into the cell after they have been released into a synapse. Their primary job is to end a chemical signal and recycle the neurotransmitter for future use.

How it works · its role

The three monoamine reuptake transporters most relevant to psychoactive substances are the SERT (SERT), the DAT (DAT), and the NET (NET). Each is sodium-coupled — it uses the natural inward flow of sodium ions to drag its neurotransmitter back into the neuron — and each cycles continuously after a neuron fires, clearing the synapse within milliseconds.

A drug can interfere with a transporter in two distinct ways. A reuptake inhibitor occupies the transporter without being carried through, preventing clearance so that neurotransmitter levels in the synapse rise and remain elevated. A substrate is itself transported into the neuron, then causes the transporter to run in reverse, actively pumping neurotransmitter outward rather than inward.

There are also vesicular transporters — most notably VMAT2 — which package monoamines into storage vesicles inside the neuron before release. Some drugs disrupt this process independently of the membrane transporters.

Relevance to substances & effects

Transporter pharmacology accounts for a large share of the subjective effects of stimulants, empathogens, and antidepressants. Cocaine blocks DAT and NET without being transported itself, preventing dopamine and norepinephrine clearance and producing its characteristic stimulation and euphoria.

Amphetamines work differently: they are substrates for DAT and NET, reversing those transporters and driving dopamine and norepinephrine outward directly — a mechanism that produces stronger and longer-lasting effects than simple reuptake inhibitor.

MDMA acts on SERT both as a blocker and a reverser, driving the large serotonin surge responsible for its empathogenic character. It also acts on DAT and NET, contributing to its stimulant dimension. SSRIs and SNRIs occupy SERT and NET without reversing them, raising synaptic levels gradually — the basis of their antidepressant effects.

Because blockers and reversers compete for the same transporter sites, combining them can amplify or blunt each other's effects in ways that are not always predictable. When two strongly serotonergic substances share overlapping transporter mechanisms, the risk of excess accumulation rises, which is why transporter profiles inform the interaction layer throughout the encyclopedia.